Jobs in Structural Biology and Related Fields


Postdoctoral position with Titia Sixma group in Netherlands Cancer Institute


The Netherlands Cancer Institute, 1066 CS Amsterdam, Germany
Application deadline: 08 Aug 2016


A post-doctoral position is available in the Netherlands Cancer Institute in the group of Titia Sixma. They are searching for an excellent candidate with expertise in protein biochemistry, X-ray crystallography and/or cryo-electron microscopy single particle reconstruction.

They study regulatory processes of ubiquitin conjugation in DNA regulation using in vitro reconstructions and structural methods. They have excellent access to high-end structural facilities such as synchrotrons (ESRF, SLS) and cryo-EM microscopy (NeCEN, Utrecht) and they share equipment with the iNEXT biophysical facility, ensuring high class instruments and support. Equipment includes high throughput crystallization, routine synchrotron access, and excellent biophysics (SPR, stopped-flow, ITC, thermophoresis, MALLS, Optim etc).

Topics of the projects center around the role of ubiquitin conjugation in DNA repair and epigenetic regulation. Integration with biology groups studying these themes is excellent, thanks to close proximity to excellent groups in field close by (Leiden, ErasmusMC, NKI)

The Netherlands Cancer Institute is a center of excellence with a high standard of biological research and an interactive atmosphere, with shared group meetings and social events. It is located in Amsterdam, with all its cultural amenities, and is close to Schiphol airport.

They share meetings and lab-space with the groups of Tassos Perrakis and Robbie Joosten, who are (among other things) interested in method development for structural biology

Applicants should write an e-mail with motivation, CV and names of three references to t.sixma@nki.nl before August 8.

Titia K. Sixma

Netherlands Cancer Institute

Plesmanlaan 121

1066 CX Amsterdam

t.sixma@nki.nl

Tel : +31205121959

1066 CS Amsterdam, Germany

Postdoctoral position with Titia Sixma group in Netherlands Cancer Institute